HAEMONETICS CORP reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
28 March
HAEMONETICS CORP has filed 1,882 SEC EDGAR filings since 07 Jun 1996

SEC filing history

Showing 651-675 of 1,000 matching filings.

Per page
25
Current page
27
4

PRIMARY DOCUMENT

Filing date
08 Jun 2017
Reporting date
06 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Jun 2017
Reporting date
06 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Jun 2017
Reporting date
06 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
NO ACT File 001-14041

AUTO-GENERATED PAPER DOCUMENT

Filing date
05 Jun 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SD File 001-14041

FORM SD

Filing date
31 May 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 May 2017
Reporting date
22 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 May 2017
Reporting date
22 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2017
Reporting date
15 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 May 2017
Reporting date
11 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14041

8-K

Filing date
08 May 2017
Reporting date
08 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14041

8-K SELMAN DEPARTURE

Filing date
05 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Apr 2017
Reporting date
24 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Mar 2017
Reporting date
06 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
08 Mar 2017
Reporting date
06 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-48277

HAEMONETICS CORPORATION

Filing date
15 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48277

SC 13G/A filing

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-48277

SEC SCHEDULE 13G

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48277

SC 13G/A filing

Filing date
07 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14041

8-K

Filing date
06 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
02 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48277

SC 13G/A filing

Filing date
12 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
12 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .